KIR/HLA ligand incompatibility in kidney transplantation

Transplantation

Volumn 84, Issue 11, 2007, Pages 1527-1533

  Kunert, Kristina ^a   Seiler, Marleen ^a   Mashreghi, Mir Farzin ^a   Klippert, Katrin ^a   Schönemann, Constanze ^a   Neumann, Konrad ^a   Pratschke, Johann ^a   Reinke, Petra ^a   Volk, Hans Dieter ^a   Kotsch, Katja ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute rejection; Kidney transplantation; Killer cell immunoglobulin like receptors (KIRs)

Indexed keywords

HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LEUKOCYTE ANTIGEN;

ACUTE GRAFT REJECTION; ADULT; ALLELE; ALLOIMMUNITY; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC INCOMPATIBILITY; GENOTYPE; GRAFT RECIPIENT; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; ORGAN DONOR; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ACUTE DISEASE; FEMALE; GENOTYPE; GRAFT REJECTION; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; LIGANDS; MALE; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS;

EID: 37349070724     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000290681.41859.41     Document Type: Article

References (51)

1. Pavlakis M, Lipman M, Strom TB. Intragraft T cell receptor transcript expression in human renal allografts. J Am Soc Nephrol 1995; 6: 281.
2. Vasconcellos LM, Schachter AD, Zheng XX, et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998; 66: 562.
3. Lipman ML, Stevens AC, Strom TB. Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol 1994; 152: 5120.
4. Lipman ML, Stevens AC, Bleackley RC, et al. The strong correlation of cytotoxic T lymphocyte-specific serine protease gene transcripts with renal allograft rejection. Transplantation 1992; 53: 73.
5. Seino KI, Fukao K, Muramoto K, et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci U S A 2001; 98: 2577.
6. McNerney ME, Lee KM, Zhou P, et al. Role of natural killer cell subsets in cardiac allograft rejection. Am J Transplant 2006 6: 505.
7. Moretta A, Bottino C, Pende D, et al. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 1990; 172: 1589.
8. Phillips JH, Gumperz JE, Parham P, Lanier LL. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 1995; 268: 403.
9. Xu J, Vallejo AN, Jiang Y, et al. Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells. J Biol Chem 2005; 280: 24277.
10. Schmidt D, Martens PB, Weyand CM, Goronzy JJ. The repertoire of CD4+ CD28- T cells in rheumatoid arthritis. Mol Med 1996; 2: 608.
11. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: Gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002; 190: 40.
12. Hsu KC, Liu XR, Selvakumar A, et al. Killer Ig-like receptor haplotype analysis by gene content: Evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 2002; 169: 5118.
13. Vilches C, Parham P. KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002; 20: 217.
14. Carrington M, Norman P. The KIR gene cluster. National Library of Medicine (US), National Center for Biotechnology Information; 2003. Available at: http://www.ncbi.nlm.nih.gov/books/bookres.fcgi/mono_003/ch1d1.pdf. Accessed October 12, 2007.
15. Williams AP, Bateman AR, Khakoo SI. Hanging in the balance: KIR and their role in disease. Mol Interv 2005; 5: 226.
16. Gumperz JE, Litwin V, Phillips JH, et al. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995; 181: 1133.
17. Dohring C, Scheidegger D, Samaridis J, et al. A human killer inhibitory receptor specific for HLA-A1,2. J Immunol 1996; 156: 3098.
18. Leung W, Iyengar R, Triplett B, et al. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 2005; 174: 6540.
19. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990; 11: 237.
20. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097.
21. Parham P, McQueen KL. Alloreactive killer cells: Hindrance and help for haematopoietic transplants. Nat Rev Immunol 2003; 3: 108.
22. Hsu KC, Keever-Taylor CA, Wilton A, et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 2005; 105: 4878.
23. Davies SM, Ruggieri L, DeFor T, et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. Blood 2002; 100: 3825.
24. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
25. Williams F, Meenagh A, Patterson C, Middleton D. Molecular diversity of the HLA-C gene identified in a caucasian population. Hum Immunol 2002; 63: 602.
26. Norman PJ, Carrington CV, Byng M, et al. Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations, Genes Immun 2002; 3: 86.
27. Becker S, Tonn T, Füssel T, et al. Assessment of killer cell immunoglobulin-like receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands. Hum Immunol 2003; 64: 183.
28. Luszczek W, Majorczyk E, Nowak I, et al. Inhibitory and activatory KIR gene frequencies in the Polish population. Int J Immunogenet 2006; 33: 167.
29. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23: 225
30. Tran TH, Mytilineos J, Scherer S, Laux G, Middleton D, Opelz G. Analysis of KIR ligand incompatibility in human renal transplantation. Transplantation 2005; 80: 1121.
31. Bishara A, Brautbar C, Zamir G, et al. Impact of HLA-C and Bw epitopes disparity on liver transplantation outcome. Hum Immunol 2005; 66: 1099.
32. Fan QR, Long EO, Wiley DC. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2001; 2: 452.
33. Yawata M, Yawata N, Draghi M, et al. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 2006; 203: 633.
34. Witt CS, Dewing C, Sayer DC, et al. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation 1999; 68: 1784.
35. Crum KA, Logue SE, Curran MD, Middleton D. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. Tissue Antigens 2000; 56: 313.
36. Toneva M, Lepage V, Lafay G, et al. Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens 2001; 57: 358.
37. Norman PJ, Stephens HA, Verity DH, et al. Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 2001; 52: 195.
38. Saulquin X, Gastinel LN, Vivier E. Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j). J Exp Med 2003; 197: 933.
39. Carrington M, Wang S, Martin MP, et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med 2005; 201: 1069.
40. Khakoo SI, Thio CL, Martin MP, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004; 305: 872.
41. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005;5: 201.
42. Winter CC, Gumperz JE, Parham P, et al. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 1998; 161: 571.
43. Rajagopalan S, Long EO. Understanding how combinations of HLA and KIR genes influence disease. J Exp Med 2005; 201: 1025.
44. Stewart CA, Laugier-Anfossi F, Vely F, et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A 2005; 102: 13224.
45. Hiby SE, Walker JJ, O'Shaughnessy KM, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200: 957.
46. Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31: 429.
47. Nelson GW, Martin MP, Gladman D, et al. Cutting edge: Heterozygote advantage in autoimmune disease: Hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004; 173: 4273.
48. Kean LS, Hamby K, Koehn B, et al. NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation. Am J Transplant 2006; 6: 292.
49. Henel G, Singh K, Cui D, et al. Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors. Blood 2006; 107: 4449.
50. Terasaki PI, Cecka JM, Gjertson DW, et al. A ten-year prediction for kidney transplant survival. In: Terasaki PI, Cecka JM, eds. Clin Transpl 1992. Los Angeles: UCLA Tissue Typing Laboratory 1993;501.
51. Frohn C, Fricke L, Puchta JC, Kirchner H. The effect of HLA-C matching on acute renal transplant rejection. Nephrol Dial Transplant 2001; 16: 355.